Literature DB >> 12452898

Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.

R Chess-Williams1.   

Abstract

1. The parasympathetic nervous system is responsible for maintaining normal bladder function, contracting the bladder smooth muscle (detrusor) and relaxing the bladder outlet during micturition. 2. Contraction of the bladder involves direct contraction via M3 receptors and an indirect 're-contraction' via M2-receptors whereby a reduction in adenylate cyclase activity reverses the relaxation induced by beta-adrenoceptor stimulation. 3. Muscarinic receptors are also located on the epithelial lining of the bladder (urothelium) where they induce the release of a diffusible factor responsible for inhibiting contraction of the underlying detrusor smooth muscle. The factor remains unidentified but is not nitric oxide, a cyclooxygenase product or adenosine triphosphate. 4. Finally, muscarinic receptors are also located prejunctionally in the bladder on cholinergic and adrenergic nerve terminals, where M1-receptors facilitate transmitter release and M2 or M4-receptors inhibit transmitter release. 5. In pathological states, changes may occur in these receptor systems resulting in bladder dysfunction. Muscarinic receptor antagonists are the main therapeutic agents available for treatment of the overactive bladder, but whether their therapeutic effect involves actions at all three locations (detrusor, prejunctional, urothelial) has yet to be established.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452898     DOI: 10.1046/j.1474-8673.2002.00258.x

Source DB:  PubMed          Journal:  Auton Autacoid Pharmacol        ISSN: 1474-8665


  65 in total

Review 1.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

Review 2.  How does the urothelium affect bladder function in health and disease? ICI-RS 2011.

Authors:  L A Birder; M Ruggieri; M Takeda; G van Koeveringe; S Veltkamp; C Korstanje; B Parsons; C H Fry
Journal:  Neurourol Urodyn       Date:  2012-01-24       Impact factor: 2.696

Review 3.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 4.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

Review 5.  Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.

Authors:  Roger Dmochowski
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

7.  The effects of reformulation: improved therapeutic index.

Authors:  Scott MacDiarmid; Bobby W Sandage; Bimal K Malhotra
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

Review 8.  Urothelial effects of oral agents for overactive bladder.

Authors:  Karl-Erik Andersson; Claudius Fullhase; Roberto Soler
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

9.  Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback.

Authors:  Klaus Deckmann; Amir Rafiq; Christian Erdmann; Christian Illig; Melanie Durschnabel; Jürgen Wess; Wolfgang Weidner; Thomas Bschleipfer; Wolfgang Kummer
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

10.  Comparative effectiveness of interventions for managing postoperative catheter-related bladder discomfort: a systematic review and network meta-analysis.

Authors:  Min Hur; Sun-Kyung Park; Hyun-Kyu Yoon; Seokha Yoo; Hyung-Chul Lee; Won Ho Kim; Jin-Tae Kim; Ja Hyeon Ku; Jae-Hyon Bahk
Journal:  J Anesth       Date:  2019-01-02       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.